Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium

GP Carter; AH Buultjens; SA Ballard; SL Baines; T Tomita; J Strachan; PDR Johnson; JK Ferguson; T Seemann; TP Stinear; BP Howden

Journal article

Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium

GP Carter, AH Buultjens, SA Ballard, SL Baines, T Tomita, J Strachan, PDR Johnson, JK Ferguson, T Seemann, TP Stinear, BP Howden

Journal of Antimicrobial Chemotherapy | OXFORD UNIV PRESS | Published : 2016

DOI: 10.1093/jac/dkw314

Abstract

Background: Enterococcus faecium is a major nosocomial pathogen causing significant morbidity and mortality worldwide. Assessment of E. faecium using MLST to understand the spread of this organism is an important component of hospital infection control measures. Recent studies, however, suggest that MLST might be inadequate for E. faecium surveillance. Objectives: To use WGS to characterize recently identified vancomycin-resistant E. faecium (VREfm) isolates nontypeable by MLST that appear to be causing a multi-jurisdictional outbreak in Australia. Methods: Illumina NextSeq and Pacific Biosciences SMRT sequencing platforms were used to determine the genome sequences of 66 non-typeable E. fae..

View full abstract

University of Melbourne Researchers

Glen Carter Author

Andrew Buultjens Author

Sarah Baines Author

Paul Johnson Author

Related Projects (3)

How bacteria evolve and cause disease

Bacteria have evolved different ways of causing disease in humans. Some bacteria produce toxins that attack the host or they have developed ..

Why is VRE (a resistant hospital infection) becoming more common in Australia?

VRE is a serious hospital superbug that has been increasing in many major hospitals around Australia, while at the same time MRSA (Golden St..

IMPROVING PREVENTION, TRACKING AND TREATMENT OF MAJOR HUMAN BACTERIAL PATHOGENS

This research fellowship will lead to a detailed understanding of the mechanisms by which bacteria become resistant to antibiotics and cause..

Grants

Awarded by National Health and Medical Research Council, Australia

Funding Acknowledgements

This work was supported by: the Department of Microbiology and Immunology at The University of Melbourne; the National Health and Medical Research Council, Australia (GNT1008549 to T. P. S., GNT1105905 to B. P. H. and GNT1027874 to P. D. R. J., T. P. S. and B. P. H.); and the Department of Health and Human Services, Victoria, Australia.